Regulatory Review of New TED Drug
Regulatory Review of New TED Drug TFC is supporting the Canadian regulatory review of the teprotumumab (Tepezza) drug for treating Thyroid Eye Disease produced by Amgen biopharmaceuticals. This review is part of the standard Health Technology Assessment process...
2024 TFC Research Grant – Thyroid Cancer
Thyroid Foundation of Canada 2024 Research Award This year’s $50K TFC research grant was awarded to Dr. Anna Sawka for her project entitled “Physicians’ Opinions on Active Surveillance and Minimally Invasive Ablative Treatment of Small, Low Risk Papillary Thyroid...
New Video on Hypothyroidism
Videos on Hypothyroidism The Thyroid Foundation of Canada and BGP Pharma ULC o/a Viatris Canada, have co-sponsored the following videos on hypothyroidism. Frequently Asked Questions with Dr. Sue D. Pedersen In this video, Dr. Sue D.Pedersen takes us through some...
RFA Facilities in Canada
Facilities for Radio Frequency Ablation of Thyroid Nodules in Canada The following facilities are currently available for RFA treatment in Canada. Southmedic Inc., the distributor of this RFA equipment in Canada, is kindly providing us with updates as new...
